Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission

被引:11
作者
Mischnik, Alexander [1 ,2 ,11 ]
Baumert, Philipp [1 ,2 ]
Hamprecht, Axel [1 ,3 ]
Rohde, Anna [1 ,4 ]
Peter, Silke [1 ,5 ]
Feihl, Susanne [1 ,6 ]
Knobloch, Johannes [1 ,7 ]
Goelz, Hanna [1 ,8 ]
Kola, Axel [1 ,4 ]
Obermann, Birgit [1 ,9 ]
Querbach, Christiane [1 ,6 ]
Willmann, Matthias [1 ,5 ]
Gebhardt, Friedemann [1 ,6 ]
Tacconelli, Evelina [1 ,10 ]
Gastmeier, Petra [1 ]
Seifert, Harald [1 ]
Kern, Winfried V. [1 ,2 ]
机构
[1] German Ctr Infect Res DZIF, Hannover, Germany
[2] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany
[3] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany
[4] Chari Univ Hosp Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Inst Hyg & Environm Med, Berlin, Germany
[5] Univ Tubingen, Inst Med Microbiol & Hygiene, Tubingen, Germany
[6] Tech Univ Munich, Inst Med Microbiol Immunol & Hygiene, Munich, Germany
[7] Univ Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hygiene, Hamburg, Germany
[8] Univ Med Ctr Freiburg, Inst Med Microbiol & Hygiene, Freiburg, Germany
[9] Univ Hosp Schleswig Holstein, Inst Med Microbiol, Lubeck, Germany
[10] Univ Hosp Tubingen, Dept Internal Med 1, Div Infect Dis, Tubingen, Germany
[11] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany
关键词
Extended-spectrum beta-lactamase; ESBL; beta-Lactam; Avibactam; AmpC; IN-VITRO ACTIVITY; BETA-LACTAMASES; AVIBACTAM; COLONIZATION; CEFTAZIDIME; BACTEREMIA;
D O I
10.1016/j.ijantimicag.2016.10.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
As part of the multicentre Antibiotic Therapy Optimisation Study (ATHOS), minimum inhibitory concentrations (MICs) were determined for cephalosporins alone and in combination with the beta-lactamase inhibitors tazobactam, clavulanic acid and avibactam against third-generation cephalosporin-resistant Escherichia coli, Klebsiella spp. and Enterobacter spp. isolates collected in German hospitals. MIC50/90 values were 0.254mg/L for cefepime/tazobactam, 0.25-2 mg/L for ceftazidime/avibactam, 0.125-0.5mg/L for ceftaroline/avibactam, 0.5-4 mg/L for cefpodoxime/clavulanic acid and 0.25-1 mg/L for aztreonam/avibactam, depending on the underlying resistance mechanism and organism. Based on in vitro testing, beta-lactam antibiotics play an important role in the treatment of infections due to beta-lactamase-producing organisms. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 50 条
  • [31] Screening for Third-Generation Cephalosporin-Resistant Bacteria Reduces the Incidence on Late-Onset Sepsis and Antibiotic use in Neonates
    Longardt, Ann Carolin
    Piening, Brar
    von Weizsaecker, Katharina
    Dame, Christof
    Buehrer, Christoph
    Garten, Lars
    [J]. KLINISCHE PADIATRIE, 2020, 232 (04): : 203 - 209
  • [32] Performance of a novel fluorogenic chimeric analog for the detection of third-generation cephalosporin resistant bacteria
    Park, Mi Jung
    Park, Yeon-Joon
    Oh, Eun-Jee
    Chang, Jiyoung
    Kim, Youngsic
    Yu, Jinkyung
    Park, Kang Gyun
    Ahn, Dae-Ro
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2016, 131 : 161 - 165
  • [33] Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections
    Ranasinghe, Ama
    Henderson, Andrew
    Cottrell, Kyra
    Tan, Cindy S. E.
    Burnard, Delaney
    Kato, Hideo
    Paterson, David L.
    Harris, Patrick N. A.
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (05):
  • [34] Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals
    Anna M. Rohde
    Janine Zweigner
    Miriam Wiese-Posselt
    Frank Schwab
    Michael Behnke
    Axel Kola
    Birgit Obermann
    Johannes K.-M. Knobloch
    Susanne Feihl
    Christiane Querbach
    Friedemann Gebhardt
    Alexander Mischnik
    Vera Ihle
    Wiebke Schröder
    Sabina Armean
    Silke Peter
    Evelina Tacconelli
    Axel Hamprecht
    Harald Seifert
    Maria J. G. T. Vehreschild
    Winfried V. Kern
    Petra Gastmeier
    [J]. Antimicrobial Resistance & Infection Control, 7
  • [35] Carriage of third-generation cephalosporin-resistant and carbapenem-resistant Enterobacterales among children in sub-Saharan Africa: a systematic review and meta-analysis
    Ruef, Micaela
    Emonet, Stephane
    Merglen, Arnaud
    Dewez, Juan Emmanuel
    Obama, Basilice Minka
    Catho, Gaud
    Andrey, Diego O.
    Kowalski, Morgane
    Harbarth, Stephan
    Combescure, Christophe
    Wagner, Noemie
    Galetto-Lacour, Annick
    [J]. ECLINICALMEDICINE, 2024, 70
  • [36] Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals
    Rohde, Anna M.
    Zweigner, Janine
    Wiese-Posselt, Miriam
    Schwab, Frank
    Behnke, Michael
    Kola, Axel
    Obermann, Birgit
    Knobloch, Johannes K. -M.
    Feihl, Susanne
    Querbach, Christiane
    Gebhardt, Friedemann
    Mischnik, Alexander
    Ihle, Vera
    Schroeder, Wiebke
    Armean, Sabina
    Peter, Silke
    Tacconelli, Evelina
    Hamprecht, Axel
    Seifert, Harald
    Vehreschild, Maria J. G. T.
    Kern, Winfried V.
    Gastmeier, Petra
    Buhl, Michael
    Busch, Dirk
    Eisenbeis, Simone
    Foerst, Gesche
    Foschi, Federico
    Gillis, Meyke
    Hansen, Dorothea
    Haecker, Georg
    Heim, Markus
    Hug, Martin
    Kaier, Klaus
    Kuepper, Fabian
    Langebartels, Georg
    Liekweg, Andrea
    Lipp, Hans-Peter
    Maertin, Nayana
    Nordmann, Mathias
    Pelzer, Andrea
    Pena-Diaz, Luis-Alberto
    Rupp, Jan
    Schroeder, Christin
    Spohn, Katrin
    Steib-Bauert, Michaela
    Vehreschild, Joerg J.
    vor dem Esche, Ulrich
    Wolke, Solvy
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [37] Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae
    Peto, Leon
    Fawcett, Nicola J.
    Crook, Derrick W.
    Peto, Tim E. A.
    Llewelyn, Martin J.
    Walker, A. Sarah
    [J]. PLOS ONE, 2019, 14 (11):
  • [38] The hospital environment versus carriage: transmission pathways for third-generation cephalosporin-resistant bacteria in blood in neonates in a low-resource country healthcare setting
    Kovacs, Dory
    Silago, Vitus
    Msanga, Delfina R.
    Mshana, Stephen E.
    Seni, Jeremiah
    Oravcova, Katarina
    Matthews, Louise
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [39] Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial
    Stewart, Adam G.
    Henderson, Andrew
    Bauer, Michelle J.
    Paterson, David L.
    Harris, Patrick N. A.
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2021, 4 (01):
  • [40] Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates
    Morrissey, Ian
    Hawser, Stephen
    Kothari, Nimmi
    Dunkel, Nathalie
    Quevedo, Juan
    Belley, Adam
    Henriksen, Anne Santerre
    Attwood, Marie
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 38 : 71 - 82